Navigation Links
MSU project may lead to new approaches against lung cancer
Date:8/17/2010

EAST LANSING, Mich. A Michigan State University researcher is analyzing the immune system's own ability to protect the body against lung cancer.

The results of the work by Alison Bauer, an assistant professor of pathobiology and diagnostic investigation in the College of Veterinary Medicine, are expected to provide new approaches to prevent, identify and treat lung cancer.

The research is funded by a $720,000 grant from the American Cancer Society.

"Chronic inflammatory lung diseases, such as asthma and chronic obstructive pulmonary disease, are risk factors in the development of lung cancer," Bauer explained. "However, activation of certain components of the immune system namely the part of our immune system that responds first to an injury, or the innate immune system may provide protection against lung cancer development."

Bauer explains her research entitled "The role of toll-like receptor 4 in mouse pulmonary neoplasia" as follows: Previous research has determined that farm and textile workers exposed to elevated levels of a bacterial component called endotoxin are at a reduced risk of developing lung cancer.

After being introduced to the body, endotoxin binds to a specific protein on cells known as "toll-like" receptors; these receptors are involved in innate immunity. The primary receptor binding endotoxin is called toll-like receptor 4 (TLR4).

Bauer and her team have previously shown that TLR4 acts in a protective manner against the development of chronic lung inflammation and lung cancer in mice; that research was published last year in the journal Molecular Cancer. With this grant, they will further investigate how and why TLR4 acts in a protective manner, focusing on the cells involved in the inflammation process in mice models.

Bauer also will look at intercellular communication, which is one way neighboring cells can communicate, and growth factor regulation. The team will investigate the role of these pathways in the protection observed through TLR4, which in other cancers is required for some chemotherapeutic drugs to be effective.


'/>"/>

Contact: Jason Cody
codyja@msu.edu
517-432-0924
Michigan State University
Source:Eurekalert

Related biology news :

1. Case Western Reserve University project ties soil conservation and river management together
2. Human Microbiome Project awards funds for technology development, data analysis and ethical research
3. Academy participates in project to discover drugs, biofuels in tropical seas
4. Field-hospital-on-a-chip project awarded to nanoengineer from UC San Diego
5. State fund advances titanium powder research, 9 other Iowa State projects
6. TECNALIA leads five projects within the VII Framework Program
7. Natural Capital Project to develop conservation software
8. Bangladesh Voter Registration Project Now Using MegaMatcher Biometric Technology to Detect and Prevent Duplicate Registrations
9. VUANCE Announces Crime Scene Security and Evidentiary Tracking Development Project
10. Human connection to our nations fisheries comes alive through oral history project
11. A BBVA Foundation project comes up with a system enabling detection of cetacean hearing loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... 2016   The Weather Company , an IBM Business ... industry-first capability in which consumers will be able to interact ... questions via voice or text and receive relevant information about ... Marketers have long sought an advertising solution that can ... personal, relevant and valuable; and can scale across millions of ...
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 27, 2016  Liquid Biotech USA ... of a Sponsored Research Agreement with The University ... (CTCs) from cancer patients.  The funding will be ... correlate with clinical outcomes in cancer patients undergoing ... then be employed to support the design of ...
(Date:6/24/2016)... Raleigh, NC (PRWEB) , ... June 24, 2016 , ... ... find the most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings ... here to read it now. , Diagnostic biomarkers are signposts in the blood, ...
(Date:6/23/2016)... -- A person commits a crime, and the detective uses ... criminal down. An outbreak of foodborne illness makes ... uses DNA evidence to track down the bacteria that caused ... not. The FDA has increasingly used a complex, cutting-edge technology ... Put as simply as possible, whole genome sequencing is a ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
Breaking Biology Technology: